Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 29 | 2023 | 267 | 9.410 |
Why?
|
Vascular Surgical Procedures | 22 | 2021 | 655 | 4.470 |
Why?
|
Lower Extremity | 19 | 2023 | 299 | 3.890 |
Why?
|
Ischemia | 14 | 2023 | 391 | 3.550 |
Why?
|
Diabetic Foot | 11 | 2020 | 154 | 3.460 |
Why?
|
Intermittent Claudication | 7 | 2020 | 56 | 3.390 |
Why?
|
Liver Transplantation | 27 | 2008 | 1112 | 2.680 |
Why?
|
Endovascular Procedures | 17 | 2022 | 516 | 2.550 |
Why?
|
Osteomyelitis | 5 | 2019 | 236 | 2.520 |
Why?
|
Gangrene | 5 | 2023 | 28 | 2.200 |
Why?
|
Aortic Aneurysm, Abdominal | 9 | 2022 | 384 | 1.990 |
Why?
|
Leg | 6 | 2022 | 226 | 1.950 |
Why?
|
Walking | 5 | 2019 | 277 | 1.820 |
Why?
|
Health Care Costs | 5 | 2017 | 674 | 1.710 |
Why?
|
Limb Salvage | 12 | 2023 | 162 | 1.650 |
Why?
|
Foot | 4 | 2023 | 104 | 1.640 |
Why?
|
Blood Vessel Prosthesis Implantation | 14 | 2020 | 705 | 1.600 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2021 | 1209 | 1.550 |
Why?
|
Aortic Rupture | 3 | 2022 | 113 | 1.480 |
Why?
|
Surgical Wound Infection | 7 | 2020 | 450 | 1.420 |
Why?
|
Islets of Langerhans Transplantation | 7 | 2006 | 35 | 1.400 |
Why?
|
Foot Ulcer | 3 | 2019 | 21 | 1.360 |
Why?
|
Models, Economic | 5 | 2017 | 101 | 1.360 |
Why?
|
Carotid Stenosis | 6 | 2021 | 176 | 1.220 |
Why?
|
Tissue and Organ Procurement | 9 | 2007 | 233 | 1.190 |
Why?
|
Exercise Tolerance | 2 | 2018 | 107 | 1.150 |
Why?
|
Healthcare Disparities | 3 | 2021 | 598 | 1.130 |
Why?
|
Foot Diseases | 2 | 2017 | 52 | 1.080 |
Why?
|
Stents | 10 | 2020 | 1096 | 1.020 |
Why?
|
Health Behavior | 3 | 2018 | 603 | 1.010 |
Why?
|
Graft Survival | 13 | 2012 | 1062 | 0.900 |
Why?
|
Medicaid | 2 | 2022 | 279 | 0.890 |
Why?
|
Treatment Outcome | 53 | 2023 | 32848 | 0.880 |
Why?
|
Bacteria | 2 | 2019 | 611 | 0.840 |
Why?
|
Risk Factors | 32 | 2023 | 17523 | 0.840 |
Why?
|
Exercise | 3 | 2019 | 1183 | 0.830 |
Why?
|
Cause of Death | 4 | 2018 | 752 | 0.820 |
Why?
|
Wound Healing | 9 | 2020 | 815 | 0.780 |
Why?
|
Texas | 15 | 2022 | 6311 | 0.770 |
Why?
|
Vascular Diseases | 2 | 2021 | 246 | 0.760 |
Why?
|
Humans | 125 | 2023 | 261506 | 0.750 |
Why?
|
Social Determinants of Health | 1 | 2021 | 97 | 0.730 |
Why?
|
Aged | 51 | 2022 | 70117 | 0.730 |
Why?
|
Vascular Grafting | 5 | 2019 | 50 | 0.720 |
Why?
|
Patient Care Bundles | 1 | 2020 | 30 | 0.720 |
Why?
|
Delay Discounting | 1 | 2019 | 8 | 0.720 |
Why?
|
Markov Chains | 6 | 2017 | 175 | 0.710 |
Why?
|
Cost-Benefit Analysis | 8 | 2017 | 945 | 0.710 |
Why?
|
Economics, Behavioral | 1 | 2019 | 12 | 0.710 |
Why?
|
Vascular Patency | 10 | 2020 | 218 | 0.710 |
Why?
|
Exercise Therapy | 2 | 2019 | 288 | 0.700 |
Why?
|
Tibia | 1 | 2020 | 131 | 0.700 |
Why?
|
Cost Savings | 2 | 2017 | 123 | 0.690 |
Why?
|
Male | 76 | 2022 | 123000 | 0.690 |
Why?
|
Time Factors | 34 | 2020 | 12926 | 0.680 |
Why?
|
Veterans Health | 2 | 2019 | 181 | 0.670 |
Why?
|
Retrospective Studies | 46 | 2023 | 37905 | 0.670 |
Why?
|
Liver Failure | 5 | 2007 | 140 | 0.660 |
Why?
|
Fenofibrate | 1 | 2018 | 57 | 0.650 |
Why?
|
Middle Aged | 55 | 2021 | 86204 | 0.650 |
Why?
|
Health Status Disparities | 1 | 2021 | 291 | 0.640 |
Why?
|
Patient Compliance | 2 | 2019 | 667 | 0.640 |
Why?
|
Health Resources | 1 | 2019 | 168 | 0.620 |
Why?
|
Soft Tissue Infections | 1 | 2018 | 102 | 0.620 |
Why?
|
Arterial Occlusive Diseases | 5 | 2019 | 160 | 0.610 |
Why?
|
Treatment Failure | 3 | 2019 | 1391 | 0.600 |
Why?
|
Fear | 2 | 2017 | 254 | 0.590 |
Why?
|
Veins | 1 | 2018 | 157 | 0.590 |
Why?
|
Avoidance Learning | 1 | 2017 | 94 | 0.580 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2016 | 23 | 0.570 |
Why?
|
Recovery of Function | 3 | 2015 | 703 | 0.570 |
Why?
|
Medical Errors | 3 | 2019 | 219 | 0.570 |
Why?
|
Postoperative Complications | 14 | 2020 | 5542 | 0.570 |
Why?
|
Liver Failure, Acute | 3 | 2006 | 88 | 0.560 |
Why?
|
Blood Vessel Prosthesis | 7 | 2019 | 412 | 0.560 |
Why?
|
Female | 66 | 2021 | 141928 | 0.540 |
Why?
|
Infection Control | 1 | 2018 | 270 | 0.540 |
Why?
|
Reoperation | 9 | 2020 | 1382 | 0.530 |
Why?
|
Bone and Bones | 1 | 2019 | 619 | 0.520 |
Why?
|
Compartment Syndromes | 1 | 2015 | 30 | 0.520 |
Why?
|
Mobility Limitation | 1 | 2015 | 31 | 0.510 |
Why?
|
Amputees | 1 | 2015 | 18 | 0.510 |
Why?
|
Saphenous Vein | 2 | 2013 | 95 | 0.510 |
Why?
|
Environment | 1 | 2016 | 190 | 0.510 |
Why?
|
Staphylococcal Infections | 2 | 2019 | 672 | 0.500 |
Why?
|
Specialties, Surgical | 2 | 2015 | 137 | 0.490 |
Why?
|
Hospitalization | 2 | 2021 | 2083 | 0.490 |
Why?
|
Hospital Costs | 2 | 2014 | 228 | 0.490 |
Why?
|
Self Concept | 1 | 2016 | 211 | 0.480 |
Why?
|
Surgeons | 1 | 2021 | 519 | 0.480 |
Why?
|
Social Behavior | 1 | 2016 | 306 | 0.470 |
Why?
|
Databases as Topic | 2 | 2011 | 133 | 0.470 |
Why?
|
Health Services Accessibility | 1 | 2019 | 761 | 0.470 |
Why?
|
Wound Closure Techniques | 1 | 2013 | 28 | 0.460 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2016 | 308 | 0.460 |
Why?
|
Severity of Illness Index | 11 | 2018 | 4320 | 0.450 |
Why?
|
United States | 18 | 2022 | 15433 | 0.450 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 2019 | 112 | 0.450 |
Why?
|
Risk Assessment | 12 | 2021 | 6869 | 0.450 |
Why?
|
Aged, 80 and over | 22 | 2021 | 29902 | 0.440 |
Why?
|
Smoking Cessation | 1 | 2018 | 712 | 0.440 |
Why?
|
Peripheral Vascular Diseases | 1 | 2013 | 136 | 0.430 |
Why?
|
Tissue Donors | 5 | 2007 | 769 | 0.420 |
Why?
|
Popliteal Artery | 1 | 2012 | 52 | 0.410 |
Why?
|
Health Care Rationing | 3 | 2007 | 94 | 0.410 |
Why?
|
Acute Kidney Injury | 2 | 2017 | 739 | 0.410 |
Why?
|
Health Status | 3 | 2016 | 590 | 0.400 |
Why?
|
Waiting Lists | 4 | 2007 | 263 | 0.390 |
Why?
|
Time-to-Treatment | 1 | 2013 | 292 | 0.390 |
Why?
|
Chi-Square Distribution | 6 | 2018 | 1323 | 0.390 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2015 | 595 | 0.390 |
Why?
|
Iliac Artery | 3 | 2019 | 108 | 0.380 |
Why?
|
Myocardial Infarction | 3 | 2018 | 1374 | 0.380 |
Why?
|
Anti-Bacterial Agents | 4 | 2019 | 2992 | 0.360 |
Why?
|
Hospitals | 3 | 2022 | 485 | 0.360 |
Why?
|
Odds Ratio | 9 | 2018 | 2316 | 0.350 |
Why?
|
Aneurysm, False | 2 | 2008 | 153 | 0.350 |
Why?
|
Graft Occlusion, Vascular | 3 | 2019 | 118 | 0.350 |
Why?
|
Multivariate Analysis | 12 | 2017 | 4298 | 0.340 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8865 | 0.340 |
Why?
|
Interprofessional Relations | 1 | 2011 | 213 | 0.330 |
Why?
|
Renal Dialysis | 3 | 2019 | 945 | 0.330 |
Why?
|
Prevalence | 4 | 2017 | 3260 | 0.330 |
Why?
|
Pain | 1 | 2017 | 1658 | 0.330 |
Why?
|
Biliary Atresia | 3 | 2006 | 191 | 0.330 |
Why?
|
Demography | 2 | 2007 | 435 | 0.320 |
Why?
|
Lymphoproliferative Disorders | 4 | 2006 | 366 | 0.320 |
Why?
|
Proportional Hazards Models | 8 | 2018 | 4988 | 0.320 |
Why?
|
Follow-Up Studies | 13 | 2017 | 14889 | 0.320 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2006 | 830 | 0.320 |
Why?
|
Veterans | 3 | 2019 | 1641 | 0.320 |
Why?
|
Leadership | 1 | 2011 | 254 | 0.320 |
Why?
|
Cohort Studies | 9 | 2020 | 9244 | 0.310 |
Why?
|
Societies, Medical | 3 | 2021 | 1335 | 0.310 |
Why?
|
Kidney Failure, Chronic | 3 | 2019 | 960 | 0.310 |
Why?
|
Angiography, Digital Subtraction | 3 | 2016 | 76 | 0.310 |
Why?
|
Angioplasty, Balloon | 3 | 2016 | 183 | 0.300 |
Why?
|
Advisory Committees | 3 | 2017 | 203 | 0.300 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2007 | 36 | 0.300 |
Why?
|
Endarterectomy, Carotid | 3 | 2015 | 121 | 0.300 |
Why?
|
General Surgery | 2 | 2015 | 326 | 0.300 |
Why?
|
Regional Blood Flow | 2 | 2020 | 276 | 0.300 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 348 | 0.290 |
Why?
|
Propionates | 1 | 2006 | 71 | 0.290 |
Why?
|
Ankle Brachial Index | 2 | 2016 | 34 | 0.280 |
Why?
|
American Heart Association | 3 | 2017 | 310 | 0.280 |
Why?
|
Policy Making | 1 | 2007 | 85 | 0.280 |
Why?
|
Immunosuppressive Agents | 5 | 2006 | 1375 | 0.280 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 585 | 0.270 |
Why?
|
Graft Rejection | 5 | 2012 | 834 | 0.270 |
Why?
|
Femoral Artery | 2 | 2020 | 210 | 0.270 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2006 | 105 | 0.270 |
Why?
|
Kaplan-Meier Estimate | 8 | 2018 | 6207 | 0.270 |
Why?
|
Length of Stay | 6 | 2018 | 1900 | 0.260 |
Why?
|
Aneurysm | 2 | 2017 | 94 | 0.260 |
Why?
|
Arachnoid | 1 | 2005 | 13 | 0.260 |
Why?
|
Patient Care Team | 1 | 2011 | 795 | 0.260 |
Why?
|
Parenteral Nutrition | 1 | 2006 | 207 | 0.260 |
Why?
|
Subarachnoid Space | 1 | 2005 | 36 | 0.260 |
Why?
|
Aortic Aneurysm | 3 | 2014 | 230 | 0.250 |
Why?
|
Incidence | 7 | 2019 | 5673 | 0.250 |
Why?
|
Sex Factors | 2 | 2021 | 2139 | 0.250 |
Why?
|
Heart Failure | 1 | 2018 | 2516 | 0.250 |
Why?
|
Survival Rate | 9 | 2019 | 12221 | 0.250 |
Why?
|
Growth Disorders | 1 | 2006 | 218 | 0.250 |
Why?
|
Attitude | 1 | 2005 | 159 | 0.250 |
Why?
|
Iatrogenic Disease | 2 | 2013 | 183 | 0.250 |
Why?
|
Cerebrospinal Fluid | 1 | 2005 | 120 | 0.250 |
Why?
|
Alanine Transaminase | 1 | 2005 | 227 | 0.240 |
Why?
|
Registries | 5 | 2018 | 2170 | 0.240 |
Why?
|
Ileal Diseases | 1 | 2004 | 27 | 0.240 |
Why?
|
Thoracic Neoplasms | 1 | 2007 | 337 | 0.240 |
Why?
|
Hepatitis C | 2 | 2006 | 524 | 0.240 |
Why?
|
Hepatic Veins | 1 | 2004 | 58 | 0.240 |
Why?
|
Carotid Artery, Common | 2 | 2015 | 91 | 0.240 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 314 | 0.240 |
Why?
|
Angioplasty | 3 | 2013 | 94 | 0.240 |
Why?
|
Adult | 22 | 2019 | 77950 | 0.240 |
Why?
|
Islets of Langerhans | 1 | 2005 | 229 | 0.240 |
Why?
|
Intussusception | 1 | 2004 | 52 | 0.230 |
Why?
|
Antimetabolites | 1 | 2004 | 69 | 0.230 |
Why?
|
Interleukin-1 | 1 | 2005 | 461 | 0.230 |
Why?
|
Ganciclovir | 1 | 2004 | 174 | 0.230 |
Why?
|
Massachusetts | 2 | 2015 | 106 | 0.230 |
Why?
|
Calcineurin Inhibitors | 1 | 2004 | 68 | 0.230 |
Why?
|
Survival Analysis | 7 | 2017 | 9180 | 0.230 |
Why?
|
Heptanoic Acids | 1 | 2003 | 96 | 0.230 |
Why?
|
Hepacivirus | 1 | 2006 | 397 | 0.230 |
Why?
|
Groin | 2 | 2013 | 74 | 0.220 |
Why?
|
Palliative Care | 1 | 2014 | 2037 | 0.220 |
Why?
|
Disease Management | 3 | 2017 | 1052 | 0.220 |
Why?
|
Chronic Disease | 4 | 2020 | 1819 | 0.220 |
Why?
|
Career Choice | 1 | 2004 | 232 | 0.220 |
Why?
|
Logistic Models | 8 | 2018 | 3441 | 0.210 |
Why?
|
Patient Selection | 4 | 2014 | 2055 | 0.210 |
Why?
|
Prosthesis-Related Infections | 2 | 2016 | 232 | 0.210 |
Why?
|
Health Surveys | 2 | 2018 | 402 | 0.210 |
Why?
|
Critical Illness | 4 | 2018 | 714 | 0.200 |
Why?
|
Cytomegalovirus | 2 | 2005 | 482 | 0.200 |
Why?
|
Quality-Adjusted Life Years | 2 | 2012 | 226 | 0.200 |
Why?
|
Lung Transplantation | 1 | 2005 | 359 | 0.200 |
Why?
|
Cost of Illness | 2 | 2017 | 498 | 0.200 |
Why?
|
Quality of Life | 4 | 2016 | 4532 | 0.200 |
Why?
|
Culturally Competent Care | 1 | 2021 | 42 | 0.200 |
Why?
|
Predictive Value of Tests | 7 | 2017 | 4892 | 0.190 |
Why?
|
Age Factors | 4 | 2018 | 5377 | 0.190 |
Why?
|
Cardiology | 2 | 2016 | 530 | 0.190 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 592 | 0.190 |
Why?
|
Adrenal Cortex Hormones | 1 | 2004 | 544 | 0.180 |
Why?
|
Comorbidity | 5 | 2014 | 2352 | 0.180 |
Why?
|
Spatial Analysis | 1 | 2019 | 35 | 0.180 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 462 | 0.180 |
Why?
|
Glomerular Filtration Rate | 2 | 2014 | 602 | 0.180 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 1581 | 0.180 |
Why?
|
Computer Simulation | 2 | 2016 | 1529 | 0.180 |
Why?
|
Geography | 1 | 2019 | 140 | 0.180 |
Why?
|
Hospitals, Low-Volume | 1 | 2019 | 53 | 0.180 |
Why?
|
Heart Transplantation | 1 | 2007 | 908 | 0.180 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 2403 | 0.180 |
Why?
|
Pyrroles | 1 | 2003 | 576 | 0.180 |
Why?
|
Surveys and Questionnaires | 4 | 2017 | 5687 | 0.180 |
Why?
|
Transportation | 1 | 2019 | 50 | 0.180 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 925 | 0.170 |
Why?
|
Operative Time | 3 | 2019 | 217 | 0.170 |
Why?
|
Aortography | 3 | 2015 | 181 | 0.170 |
Why?
|
Sirolimus | 1 | 2003 | 814 | 0.170 |
Why?
|
Appointments and Schedules | 1 | 2019 | 98 | 0.170 |
Why?
|
Hospitals, High-Volume | 1 | 2019 | 77 | 0.170 |
Why?
|
Students, Medical | 1 | 2004 | 399 | 0.170 |
Why?
|
Cadaver | 4 | 2007 | 237 | 0.170 |
Why?
|
Enterococcus | 1 | 2019 | 59 | 0.170 |
Why?
|
History, 20th Century | 2 | 2015 | 574 | 0.170 |
Why?
|
Operating Rooms | 1 | 2019 | 122 | 0.160 |
Why?
|
Healthy Lifestyle | 1 | 2018 | 44 | 0.160 |
Why?
|
Child, Preschool | 11 | 2008 | 16273 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 6 | 2015 | 7551 | 0.160 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 78 | 0.160 |
Why?
|
Wound Infection | 1 | 2018 | 54 | 0.160 |
Why?
|
Liver | 5 | 2008 | 2961 | 0.160 |
Why?
|
Medicare | 1 | 2022 | 860 | 0.160 |
Why?
|
Venous Thrombosis | 2 | 2014 | 384 | 0.160 |
Why?
|
Arteries | 1 | 2019 | 274 | 0.160 |
Why?
|
Organ Sparing Treatments | 1 | 2019 | 277 | 0.160 |
Why?
|
Diabetic Neuropathies | 2 | 2017 | 101 | 0.150 |
Why?
|
Epstein-Barr Virus Infections | 3 | 2006 | 489 | 0.150 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2015 | 60 | 0.150 |
Why?
|
Adolescent | 12 | 2019 | 31252 | 0.150 |
Why?
|
Reperfusion Injury | 2 | 2008 | 145 | 0.150 |
Why?
|
Prognosis | 7 | 2018 | 21713 | 0.150 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 7 | 0.150 |
Why?
|
Prosthesis Design | 5 | 2020 | 749 | 0.150 |
Why?
|
Patient Readmission | 3 | 2020 | 548 | 0.140 |
Why?
|
Tertiary Care Centers | 1 | 2018 | 403 | 0.140 |
Why?
|
Serum Albumin | 1 | 2017 | 257 | 0.140 |
Why?
|
Reproducibility of Results | 4 | 2016 | 6009 | 0.140 |
Why?
|
Catheters, Indwelling | 1 | 2019 | 374 | 0.140 |
Why?
|
Patient Education as Topic | 1 | 2021 | 748 | 0.140 |
Why?
|
Blood Transfusion | 2 | 2013 | 583 | 0.140 |
Why?
|
Recurrence | 4 | 2019 | 4758 | 0.140 |
Why?
|
Propensity Score | 3 | 2020 | 750 | 0.140 |
Why?
|
Angiography | 2 | 2015 | 360 | 0.140 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 306 | 0.130 |
Why?
|
Learning Curve | 2 | 2012 | 68 | 0.130 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 383 | 0.130 |
Why?
|
Pancreas Transplantation | 2 | 2006 | 46 | 0.130 |
Why?
|
Algorithms | 2 | 2006 | 3890 | 0.130 |
Why?
|
Prospective Studies | 9 | 2019 | 12873 | 0.130 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2016 | 787 | 0.130 |
Why?
|
Artificial Limbs | 1 | 2015 | 15 | 0.130 |
Why?
|
Low Back Pain | 1 | 2016 | 83 | 0.130 |
Why?
|
Osteoarthritis | 1 | 2016 | 94 | 0.130 |
Why?
|
Fasciotomy | 1 | 2015 | 43 | 0.130 |
Why?
|
Hemoglobins | 2 | 2017 | 477 | 0.130 |
Why?
|
Hepatocytes | 3 | 2007 | 351 | 0.130 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 144 | 0.130 |
Why?
|
Silver Compounds | 1 | 2014 | 6 | 0.130 |
Why?
|
History, 18th Century | 1 | 2015 | 89 | 0.130 |
Why?
|
Polyethylenes | 1 | 2014 | 12 | 0.130 |
Why?
|
Alginates | 1 | 2014 | 16 | 0.130 |
Why?
|
Self Report | 1 | 2018 | 756 | 0.130 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 548 | 0.130 |
Why?
|
Polyesters | 1 | 2014 | 53 | 0.120 |
Why?
|
Prosthesis Fitting | 1 | 2014 | 16 | 0.120 |
Why?
|
History, 19th Century | 1 | 2015 | 154 | 0.120 |
Why?
|
Age Distribution | 2 | 2006 | 698 | 0.120 |
Why?
|
Databases, Factual | 3 | 2006 | 2218 | 0.120 |
Why?
|
Bandages | 1 | 2014 | 71 | 0.120 |
Why?
|
Decompression, Surgical | 1 | 2015 | 143 | 0.120 |
Why?
|
Chemistry, Clinical | 1 | 2014 | 18 | 0.120 |
Why?
|
Nervous System Diseases | 1 | 2019 | 500 | 0.120 |
Why?
|
Graft vs Host Disease | 1 | 2005 | 2638 | 0.120 |
Why?
|
Renal Artery Obstruction | 1 | 2014 | 38 | 0.120 |
Why?
|
Disease Progression | 4 | 2016 | 6682 | 0.120 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2014 | 68 | 0.120 |
Why?
|
Vancomycin | 2 | 2013 | 273 | 0.120 |
Why?
|
Vena Cava Filters | 1 | 2014 | 88 | 0.120 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 40 | 0.120 |
Why?
|
Foreign-Body Migration | 1 | 2014 | 117 | 0.120 |
Why?
|
Child | 11 | 2008 | 29154 | 0.120 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 121 | 0.120 |
Why?
|
Patient Safety | 1 | 2019 | 649 | 0.110 |
Why?
|
Vascular Access Devices | 1 | 2013 | 51 | 0.110 |
Why?
|
Pilot Projects | 2 | 2017 | 2803 | 0.110 |
Why?
|
United States Department of Veterans Affairs | 1 | 2017 | 605 | 0.110 |
Why?
|
Herpesvirus 4, Human | 3 | 2006 | 966 | 0.110 |
Why?
|
Amputation Stumps | 1 | 2012 | 6 | 0.110 |
Why?
|
Polymethyl Methacrylate | 1 | 2012 | 41 | 0.110 |
Why?
|
Heart Diseases | 2 | 2017 | 732 | 0.110 |
Why?
|
Acute Disease | 2 | 2015 | 2422 | 0.110 |
Why?
|
Emergencies | 1 | 2014 | 202 | 0.110 |
Why?
|
Skin Transplantation | 1 | 2013 | 173 | 0.110 |
Why?
|
Polytetrafluoroethylene | 1 | 2013 | 113 | 0.110 |
Why?
|
Biopsy | 2 | 2019 | 3443 | 0.110 |
Why?
|
Coronary Stenosis | 1 | 2013 | 117 | 0.110 |
Why?
|
Mental Health | 1 | 2016 | 415 | 0.110 |
Why?
|
Surgical Wound Dehiscence | 1 | 2013 | 129 | 0.100 |
Why?
|
Quality Improvement | 1 | 2019 | 851 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2014 | 206 | 0.100 |
Why?
|
Radiography | 4 | 2013 | 1904 | 0.100 |
Why?
|
Anemia | 1 | 2017 | 689 | 0.100 |
Why?
|
Balloon Occlusion | 1 | 2011 | 49 | 0.100 |
Why?
|
Infant | 8 | 2007 | 13310 | 0.100 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2012 | 157 | 0.100 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2012 | 158 | 0.100 |
Why?
|
Transplantation, Homologous | 3 | 2007 | 2843 | 0.100 |
Why?
|
Equipment Design | 1 | 2015 | 1204 | 0.100 |
Why?
|
Postoperative Hemorrhage | 1 | 2013 | 162 | 0.100 |
Why?
|
Drug Carriers | 1 | 2012 | 327 | 0.100 |
Why?
|
Device Removal | 1 | 2013 | 337 | 0.100 |
Why?
|
Antibiotic Prophylaxis | 1 | 2013 | 181 | 0.100 |
Why?
|
Bile | 2 | 2008 | 81 | 0.100 |
Why?
|
Microbial Sensitivity Tests | 1 | 2014 | 994 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2014 | 321 | 0.100 |
Why?
|
Database Management Systems | 1 | 2010 | 63 | 0.090 |
Why?
|
Apoptosis | 1 | 2005 | 7591 | 0.090 |
Why?
|
Catheterization, Central Venous | 1 | 2013 | 354 | 0.090 |
Why?
|
Kidney | 3 | 2016 | 2146 | 0.090 |
Why?
|
Anastomosis, Surgical | 1 | 2012 | 371 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 980 | 0.090 |
Why?
|
Viral Load | 3 | 2006 | 493 | 0.090 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 4314 | 0.090 |
Why?
|
DNA, Viral | 3 | 2006 | 694 | 0.090 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 1085 | 0.090 |
Why?
|
Cognition Disorders | 1 | 2015 | 786 | 0.090 |
Why?
|
Cold Ischemia | 1 | 2008 | 22 | 0.080 |
Why?
|
Anesthesia | 1 | 2012 | 296 | 0.080 |
Why?
|
Aspartate Aminotransferases | 2 | 2008 | 153 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2018 | 10001 | 0.080 |
Why?
|
Body Height | 2 | 2007 | 231 | 0.080 |
Why?
|
P-Selectin | 1 | 2008 | 124 | 0.080 |
Why?
|
Laminectomy | 1 | 2008 | 52 | 0.080 |
Why?
|
Surgical Stapling | 1 | 2008 | 36 | 0.080 |
Why?
|
Bile Canaliculi | 1 | 2007 | 6 | 0.080 |
Why?
|
Perfusion | 2 | 2008 | 293 | 0.080 |
Why?
|
Phlebography | 1 | 2008 | 76 | 0.080 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 482 | 0.080 |
Why?
|
Transplants | 1 | 2008 | 52 | 0.080 |
Why?
|
Research Design | 3 | 2010 | 1544 | 0.080 |
Why?
|
Bradycardia | 1 | 2007 | 70 | 0.080 |
Why?
|
Contrast Media | 1 | 2014 | 1472 | 0.070 |
Why?
|
Thrombectomy | 1 | 2008 | 158 | 0.070 |
Why?
|
Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2007 | 34 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2013 | 927 | 0.070 |
Why?
|
Risk Adjustment | 1 | 2007 | 83 | 0.070 |
Why?
|
Models, Statistical | 2 | 2019 | 1171 | 0.070 |
Why?
|
Lumbar Vertebrae | 1 | 2008 | 245 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2012 | 622 | 0.070 |
Why?
|
Resource Allocation | 1 | 2007 | 67 | 0.070 |
Why?
|
Government Regulation | 1 | 2007 | 67 | 0.070 |
Why?
|
Likelihood Functions | 1 | 2007 | 233 | 0.070 |
Why?
|
Hemangioendothelioma | 1 | 2006 | 35 | 0.070 |
Why?
|
Biomarkers | 4 | 2017 | 5047 | 0.070 |
Why?
|
Social Justice | 1 | 2007 | 61 | 0.070 |
Why?
|
Anticoagulants | 2 | 2014 | 787 | 0.070 |
Why?
|
Cation Transport Proteins | 1 | 2007 | 199 | 0.070 |
Why?
|
Cross Circulation | 1 | 2005 | 5 | 0.070 |
Why?
|
Hemoperfusion | 1 | 2005 | 5 | 0.070 |
Why?
|
Liver, Artificial | 1 | 2005 | 8 | 0.070 |
Why?
|
Plasma Cells | 1 | 2007 | 192 | 0.070 |
Why?
|
Hypotension | 1 | 2007 | 210 | 0.070 |
Why?
|
Dialysis | 1 | 2005 | 23 | 0.070 |
Why?
|
Thrombolytic Therapy | 1 | 2008 | 257 | 0.070 |
Why?
|
CD3 Complex | 1 | 2006 | 314 | 0.070 |
Why?
|
Hemodiafiltration | 1 | 2005 | 18 | 0.070 |
Why?
|
Depression | 1 | 2016 | 1715 | 0.070 |
Why?
|
Life Support Care | 1 | 2006 | 50 | 0.070 |
Why?
|
Plasmapheresis | 1 | 2005 | 61 | 0.070 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2007 | 334 | 0.070 |
Why?
|
Extracorporeal Circulation | 1 | 2005 | 43 | 0.070 |
Why?
|
Budd-Chiari Syndrome | 1 | 2005 | 10 | 0.070 |
Why?
|
Hemochromatosis | 1 | 2005 | 35 | 0.070 |
Why?
|
Anthropometry | 1 | 2006 | 269 | 0.070 |
Why?
|
Portal Pressure | 1 | 2005 | 13 | 0.070 |
Why?
|
Antibodies | 1 | 2008 | 838 | 0.070 |
Why?
|
Ependyma | 1 | 2005 | 13 | 0.070 |
Why?
|
Hyperplasia | 1 | 2007 | 557 | 0.070 |
Why?
|
Elective Surgical Procedures | 2 | 2017 | 250 | 0.070 |
Why?
|
Choroid Plexus | 1 | 2005 | 31 | 0.060 |
Why?
|
Adenosine Triphosphatases | 1 | 2007 | 435 | 0.060 |
Why?
|
Kupffer Cells | 1 | 2005 | 42 | 0.060 |
Why?
|
Primates | 1 | 2005 | 128 | 0.060 |
Why?
|
Liver Diseases | 2 | 2007 | 574 | 0.060 |
Why?
|
Residence Characteristics | 1 | 2007 | 348 | 0.060 |
Why?
|
History, 21st Century | 1 | 2007 | 441 | 0.060 |
Why?
|
Body Weight | 2 | 2007 | 1293 | 0.060 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2005 | 100 | 0.060 |
Why?
|
Hypothyroidism | 1 | 2006 | 204 | 0.060 |
Why?
|
Cerebral Ventricles | 1 | 2005 | 98 | 0.060 |
Why?
|
Immunity, Cellular | 1 | 2006 | 419 | 0.060 |
Why?
|
Clinical Competence | 1 | 2012 | 1270 | 0.060 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2007 | 500 | 0.060 |
Why?
|
Iron | 1 | 2007 | 376 | 0.060 |
Why?
|
Muromonab-CD3 | 1 | 2004 | 19 | 0.060 |
Why?
|
Diabetes Complications | 1 | 2006 | 305 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 215 | 0.060 |
Why?
|
Probability | 1 | 2006 | 866 | 0.060 |
Why?
|
Propylene Glycols | 1 | 2004 | 36 | 0.060 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 261 | 0.060 |
Why?
|
Sphingosine | 1 | 2004 | 55 | 0.060 |
Why?
|
Nutritional Status | 1 | 2006 | 337 | 0.060 |
Why?
|
Fingolimod Hydrochloride | 1 | 2004 | 45 | 0.060 |
Why?
|
Albumins | 1 | 2005 | 258 | 0.060 |
Why?
|
Creatinine | 1 | 2006 | 531 | 0.060 |
Why?
|
Hypoglycemia | 1 | 2005 | 213 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2006 | 8223 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2005 | 313 | 0.060 |
Why?
|
Malnutrition | 1 | 2006 | 218 | 0.060 |
Why?
|
Administration, Topical | 2 | 2014 | 257 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2005 | 1082 | 0.060 |
Why?
|
Young Adult | 2 | 2019 | 21445 | 0.060 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 551 | 0.060 |
Why?
|
Body Mass Index | 2 | 2012 | 2203 | 0.060 |
Why?
|
Cyclosporine | 1 | 2004 | 278 | 0.050 |
Why?
|
Consensus | 2 | 2017 | 978 | 0.050 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 483 | 0.050 |
Why?
|
Bile Duct Neoplasms | 1 | 2007 | 493 | 0.050 |
Why?
|
Portal Vein | 1 | 2005 | 355 | 0.050 |
Why?
|
Cholangiocarcinoma | 1 | 2007 | 493 | 0.050 |
Why?
|
Drug Interactions | 1 | 2003 | 553 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2006 | 2307 | 0.050 |
Why?
|
Lymphocytes | 1 | 2006 | 1234 | 0.050 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2004 | 864 | 0.050 |
Why?
|
Emotions | 1 | 2005 | 562 | 0.050 |
Why?
|
Swine | 1 | 2005 | 1541 | 0.050 |
Why?
|
ROC Curve | 2 | 2015 | 1183 | 0.050 |
Why?
|
Survivors | 1 | 2007 | 1031 | 0.050 |
Why?
|
Spinal Cord | 1 | 2005 | 690 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2005 | 644 | 0.050 |
Why?
|
Suture Techniques | 2 | 2013 | 319 | 0.050 |
Why?
|
Metatarsus | 1 | 2020 | 2 | 0.050 |
Why?
|
Pancreas | 1 | 2004 | 718 | 0.050 |
Why?
|
Blood Glucose | 1 | 2005 | 1244 | 0.050 |
Why?
|
Knee | 1 | 2020 | 33 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2006 | 755 | 0.050 |
Why?
|
Comparative Effectiveness Research | 1 | 2020 | 126 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2005 | 1945 | 0.040 |
Why?
|
Metals | 1 | 2020 | 155 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 2594 | 0.040 |
Why?
|
Animals | 6 | 2008 | 59536 | 0.040 |
Why?
|
Salvage Therapy | 1 | 2008 | 2054 | 0.040 |
Why?
|
Linear Models | 2 | 2012 | 1085 | 0.040 |
Why?
|
Drug-Eluting Stents | 1 | 2020 | 131 | 0.040 |
Why?
|
Fatigue | 1 | 2005 | 1239 | 0.040 |
Why?
|
Hepatectomy | 1 | 2005 | 1011 | 0.040 |
Why?
|
Rituximab | 1 | 2004 | 1528 | 0.040 |
Why?
|
Up-Regulation | 1 | 2005 | 2450 | 0.040 |
Why?
|
Trauma Centers | 1 | 2019 | 163 | 0.040 |
Why?
|
Anxiety | 1 | 2005 | 1179 | 0.040 |
Why?
|
Respiratory Tract Diseases | 1 | 2017 | 111 | 0.040 |
Why?
|
Cytokines | 1 | 2006 | 2809 | 0.040 |
Why?
|
Burnout, Professional | 1 | 2019 | 205 | 0.030 |
Why?
|
Regression Analysis | 1 | 2019 | 1546 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 4971 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 849 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 452 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2014 | 7 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2014 | 15 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2004 | 1054 | 0.030 |
Why?
|
Inflammation | 1 | 2005 | 2522 | 0.030 |
Why?
|
Boston | 1 | 2014 | 108 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 130 | 0.030 |
Why?
|
Computed Tomography Angiography | 1 | 2016 | 234 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2005 | 2819 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2017 | 577 | 0.030 |
Why?
|
Citric Acid | 1 | 2014 | 54 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2019 | 2588 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2015 | 475 | 0.030 |
Why?
|
Blood Specimen Collection | 1 | 2014 | 93 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2008 | 2063 | 0.030 |
Why?
|
Jugular Veins | 1 | 2013 | 107 | 0.030 |
Why?
|
Powders | 1 | 2013 | 23 | 0.030 |
Why?
|
Tobramycin | 1 | 2012 | 21 | 0.030 |
Why?
|
Antisepsis | 1 | 2012 | 12 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2014 | 573 | 0.030 |
Why?
|
Disarticulation | 1 | 2012 | 5 | 0.030 |
Why?
|
Anesthesia Recovery Period | 1 | 2012 | 36 | 0.030 |
Why?
|
Respiration Disorders | 1 | 2013 | 45 | 0.030 |
Why?
|
Patient Transfer | 1 | 2014 | 137 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2017 | 445 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2013 | 90 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2017 | 717 | 0.030 |
Why?
|
Gentamicins | 1 | 2012 | 90 | 0.030 |
Why?
|
Hip Joint | 1 | 2012 | 54 | 0.030 |
Why?
|
Transfusion Reaction | 1 | 2013 | 102 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2008 | 3578 | 0.030 |
Why?
|
Forecasting | 1 | 2015 | 694 | 0.030 |
Why?
|
Heparin | 1 | 2014 | 360 | 0.030 |
Why?
|
Intraoperative Care | 1 | 2013 | 259 | 0.030 |
Why?
|
Morbidity | 1 | 2012 | 397 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 4367 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2015 | 1178 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2011 | 310 | 0.020 |
Why?
|
Immunotherapy | 1 | 2004 | 3341 | 0.020 |
Why?
|
Acute Coronary Syndrome | 1 | 2013 | 259 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2019 | 6100 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2006 | 4557 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2011 | 305 | 0.020 |
Why?
|
Raffinose | 1 | 2008 | 6 | 0.020 |
Why?
|
Rats | 2 | 2008 | 6086 | 0.020 |
Why?
|
Glutathione Disulfide | 1 | 2008 | 20 | 0.020 |
Why?
|
Cognition | 1 | 2015 | 968 | 0.020 |
Why?
|
Organ Preservation Solutions | 1 | 2008 | 20 | 0.020 |
Why?
|
Allopurinol | 1 | 2008 | 54 | 0.020 |
Why?
|
Antiviral Agents | 2 | 2006 | 1230 | 0.020 |
Why?
|
Polyvinyl Alcohol | 1 | 2008 | 19 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2008 | 221 | 0.020 |
Why?
|
Aspartate Aminotransferase, Mitochondrial | 1 | 2007 | 2 | 0.020 |
Why?
|
Patient Discharge | 1 | 2013 | 661 | 0.020 |
Why?
|
Renal Artery | 1 | 2008 | 79 | 0.020 |
Why?
|
Splenic Artery | 1 | 2008 | 50 | 0.020 |
Why?
|
Ceruloplasmin | 1 | 2007 | 35 | 0.020 |
Why?
|
Copper-transporting ATPases | 1 | 2007 | 44 | 0.020 |
Why?
|
Trace Elements | 1 | 2007 | 33 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2008 | 131 | 0.020 |
Why?
|
Stroke | 1 | 2016 | 1144 | 0.020 |
Why?
|
Sus scrofa | 1 | 2008 | 169 | 0.020 |
Why?
|
Platinum | 1 | 2008 | 138 | 0.020 |
Why?
|
Splenectomy | 1 | 2008 | 158 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2008 | 311 | 0.020 |
Why?
|
Necrosis | 1 | 2008 | 580 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 2315 | 0.020 |
Why?
|
Palatine Tonsil | 1 | 2007 | 53 | 0.020 |
Why?
|
Adenosine | 1 | 2008 | 289 | 0.020 |
Why?
|
Glutathione | 1 | 2008 | 368 | 0.020 |
Why?
|
Biological Transport | 1 | 2007 | 597 | 0.020 |
Why?
|
Living Donors | 1 | 2007 | 171 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2008 | 1618 | 0.020 |
Why?
|
Salivary Glands, Minor | 1 | 2005 | 33 | 0.020 |
Why?
|
Metabolism, Inborn Errors | 1 | 2007 | 108 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2008 | 369 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2007 | 11538 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2005 | 266 | 0.020 |
Why?
|
Actins | 1 | 2007 | 608 | 0.020 |
Why?
|
Hypertension | 1 | 2014 | 1503 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 571 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2006 | 234 | 0.020 |
Why?
|
Neutrophils | 1 | 2008 | 835 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2006 | 183 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2006 | 178 | 0.010 |
Why?
|
Endoscopy | 1 | 2007 | 479 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2005 | 403 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2006 | 330 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 709 | 0.010 |
Why?
|
Insulin | 1 | 2008 | 1454 | 0.010 |
Why?
|
Blood Pressure | 1 | 2008 | 1467 | 0.010 |
Why?
|
NF-kappa B | 1 | 2008 | 1549 | 0.010 |
Why?
|
Remission Induction | 1 | 2006 | 3569 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 3203 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 3639 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 6150 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 7222 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 7702 | 0.010 |
Why?
|